Axway’s Controlled Substance Ordering System (CSOS) makes it easy for buyers and suppliers of regulated pharmaceuticals to reduce operational expenses and increase security while ensuring real-time compliance with U.S. Drug Enforcement Administration (DEA) regulations.
CSOS is compliant with CFR21 Part 11 and meets FIPS140 requirements, enabling organizations to replace the DEA’s costly paper-based Form 222 with the electronic Form e222. By providing all of the functionality you need to manage an electronic B2B relationship — including certificate management, trading partner/community management, secure communications, encryption, digital signatures, alerting, and tracking — CSOS is eliminating billions in costs from the healthcare supply chain and drastically cutting delivery times.
CSOS generates complete audit trails that show all archived orders, acknowledgements, and shipping documents. And real-time visibility and alerting allows you to be more responsive to your partners and helps you comply with DEA audit requests quickly and efficiently.
CSOS is easy to implement because it leverages pre-configured profiles for existing CSOS customers, including the “Big Three” pharma distributors, 70% of regional distributors, and many of the top pharmaceutical manufacturers and retailers. CSOS also provides a provisioning framework wizard for easily adding thousands of pharmacies to the CSOS trading community.
For buyers such as pharmacies, practitioners, and distributors, regardless of size, CSOS:
For suppliers, such as manufacturers and distributors, CSOS: